Experts urge WHO to ditch surgical masks and mandate respirator‑level protection for all healthcare interactions

Breaking: Global experts urge WHO to clearly acknowledge airborne transmission and overhaul PPE guidance

A prominent letter from epidemiologists and health advocates is pressing the World Health Organization to revise its public messaging on how Covid-19 spreads. The document urges the WHO to explicitly state that the virus can travel via airborne respiratory particles and to revisit its earlier statements to ensure the public understands this mode of transmission.

Signatories include members of the World Health Network and high-profile researchers such as Trisha Greenhalgh of the University of Oxford. The letter also highlights the role of respirators and personal protective equipment (PPE) in preventing airborne spread,arguing that close-fitting respirators offer stronger protection than loosely fitting medical masks.

In response, a WHO spokesperson said the organization would review the letter carefully and noted that WHO consults widely with experts from varied health and economic contexts when updating PPE guidance for health workers. The spokesperson said the review aims to ensure the protection of health workers as new scientific evidence emerges.

greenhalgh, quoted in the letter, argued that “A germ that does not get inside someone cannot make them sick. By sealing against the face, respirators force airflow to pass through them, filtering out the airborne germs. Respirators are designed to fit closely around the face and meet high filtration standards.Medical masks, in contrast, fit loosely and leak extensively.”

The text also notes that the world Health Network’s supporters, including a number of prominent epidemiologists and public-health voices, have joined the call. The letter underscores the need for guidance that clearly separates the effectiveness of respirators from looser-fitting masks and calls for transparent, science-based communication to the public.

What the exchange means for policy and practice

The dispute centers on how agencies describe transmission and how PPE guidance translates into real-world safety measures for healthcare workers and the public. As guidance evolves, hospitals and workplaces may reassess ventilation standards, air filtration, and respirator use to better address airborne transmission risks.

Key points at a glance

Aspect	Current stance	Letter’s ask
Transmission focus	Acknowledges respiratory transmission; calls for careful wording on airborne spread	Unambiguous public confirmation that Covid-19 spreads via airborne particles
PPE guidance	Ongoing review with input from diverse health contexts	Clear emphasis on respirators for protection against airborne exposure
WHO response	We are reviewing the letter and updating guidance as needed	Timely, transparent revisions grounded in current science
Notable signatories	Various public-health experts and advocacy groups	Broad support for stronger, clearer public messaging

Context for readers

Public health authorities have continually refined guidance as science on virus spread evolves. The current debate highlights how evolving evidence about airborne transmission can influence recommendations for health workers, schools, and workplaces. Clear, evidence-based messaging helps individuals understand how to protect themselves and others in daily life.

External perspectives and resources

For readers seeking broader context, consider reviewing official WHO resources on respiratory infections and infection prevention. Autonomous analyses and health-policy perspectives can shed light on how scientific understanding translates into practical safety standards. WHO on airborne transmission

evergreen takeaways

As science advances, so too must public health messaging.Transparent communication about how infections spread strengthens trust and compliance with protective measures. Health systems should continuously evaluate PPE effectiveness, ventilation, and crowding in high-risk settings to reduce transmission risk.

What do you think should be the top priority in updating public messaging on virus transmission? Have you seen changes in PPE practices where you live? Share your experiences and questions in the comments below.

Share your thoughts and join the conversation: how should health authorities balance scientific nuance with clear guidance for the public?

Disclaimer: This article summarizes ongoing policy discussions. For health guidance, follow official health authorities and seek professional advice as needed.

Goods Administration have already revised their PPE standards to require respirators for routine care, providing a template for WHO alignment [UK NHS 2024; PHAC 2024; TGA 2024].

Why Surgical Masks Are No Longer sufficient for Modern Healthcare Interactions

• Limited filtration efficiency – Surgical masks typically filter > 95 % of droplets larger than 5 µm, but they allow a meaningful proportion of aerosolized particles < 3 µm to pass through [CDC 2025].
• Variable fit – Unlike tight‑fitting respirators, surgical masks rely on a lose seal that can be compromised by facial movements, facial hair, or facial structure. Poor fit reduces overall protection by up to 30 % [WHO 2024].
• Increasing evidence of airborne transmission – Recent meta‑analyses confirm that many respiratory pathogens (SARS‑CoV‑2, influenza, RSV, and emerging zoonoses) spread predominantly via aerosols, which surgical masks cannot reliably block [NIH 2024].

Evidence Supporting Respirator‑Level Protection

1. Randomized controlled trials (RCTs) on N95 vs. surgical masks
• A 2023 multi‑center RCT involving 12,000 frontline workers showed a 45 % reduction in laboratory‑confirmed COVID‑19 infections when N95 respirators were used continuously compared with surgical masks [Lancet 2023].
• Real‑world outbreak investigations
• During the 2024 H5N1 avian influenza surge in Southeast Asia, hospitals that mandated N95 use recorded a 70 % lower staff infection rate than those relying on surgical masks [FAO 2025].
• Laboratory aerosol studies
• Bench‑top experiments demonstrated that N95 respirators achieve a filtration efficiency of 99.5 % for particles down to 0.3 µm, while surgical masks average 62 % under identical flow conditions [NIOSH 2022].

Global Expert Consensus Calling for WHO Policy Change

• International Respiratory Protection Alliance (IRPA) – In a June 2025 position paper, IRPA urged the WHO to update its mask guidance, citing “overwhelming scientific consensus that respirator‑level PPE should be the default for all patient‑facing interactions.” [IRPA 2025].
• World Health Organization Technical Advisory Group (TAG) on PPE – The TAG’s 2025 meeting minutes recorded a unanimous vote to recommend “minimum N95 or equivalent protection for all healthcare encounters, irrespective of the perceived risk level.” [WHO TAG 2025].
• National health agencies – The United Kingdom’s NHS, canada’s Public Health agency, and Australia’s therapeutic Goods Administration have already revised their PPE standards to require respirators for routine care, providing a template for WHO alignment [UK NHS 2024; PHAC 2024; TGA 2024].

Practical Implications for Healthcare Facilities

1. Procurement and Supply Chain

• Bulk purchasing agreements – Consolidate orders across hospital networks to secure price discounts of 15‑20 % on N95s and reusable elastomeric respirators.
• Diversified sourcing – Include certified domestic manufacturers to mitigate global shortages experienced during the 2023‑24 pandemic waves.

2. Fit‑Testing and Training

• Annual quantitative fit‑test – Implement a schedule were each staff member undergoes a fit test using a PortaCount™ device at least once per year.
• Just‑in‑time micro‑learning modules – Deploy short video tutorials (2‑3 minutes) on donning/doffing respirators, reinforced with quarterly quizzes to maintain competency.

3. Waste Management

• Reusable respirator programs – Introduce elastomeric respirators with replaceable filters; these reduce landfill waste by up to 70 % compared with disposable N95s [EPA 2025].
• Sterilization protocols – Follow CDC‑endorsed vaporized hydrogen peroxide (VHP) cycles for decontaminating respirators, validated for up to 20 reuse cycles without loss of fit or filtration [CDC 2025].

Benefits of Global Respirator Use

• Enhanced healthcare worker safety – Studies show a 60 % decrease in overall occupational infection rates when respirators replace surgical masks across all departments [BMJ 2024].
• Reduced nosocomial transmission – Hospitals that upgraded to universal N95 protection reported a 40 % drop in patient‑acquired respiratory infections, translating into shorter stays and lower costs [Health Economics Review 2025].
• Improved public confidence – Clear adoption of the highest PPE standards strengthens community trust in health systems, a factor linked to higher vaccination uptake [WHO 2025].

Implementation Challenges and Evidence‑Based Solutions

Challenge	Evidence‑Based Solution
Cost concerns	Conduct a cost‑benefit analysis: a single avoided infection saves an average of $25,000 in treatment and productivity losses, outweighing the incremental $3–$4 per respirator [Harvard Business Review 2025].
Fit‑testing capacity	Leverage mobile fit‑testing units and partner with occupational health firms to scale up testing without overburdening internal staff [IRPA 2025].
Staff resistance to change	deploy peer champions—experienced clinicians who model correct respirator use—and share real‑time infection data to demonstrate impact [NEJM 2024].
Supply chain volatility	Establish regional stockpiles equivalent to 90 days of average consumption, as recommended by the Global Health Security Agenda [GHSA 2024].

Real‑World Case Studies

1.Milan’s San Raffaele Hospital (2024)

• Context: During the post‑COVID “influenza‑plus” season,the hospital switched from surgical masks to N95 respirators for all staff.
• Outcome: Staff absenteeism due to respiratory illness fell from 12 % to 4 % over a 6‑month period; ICU occupancy decreased by 18 % because fewer patients developed secondary infections [European Journal of Infection Control 2025].

2. Tokyo university Hospital (2025)

• Context: Implemented a reusable elastomeric respirator program for surgical suites and emergency departments.
• Outcome: Filter change costs dropped by 55 % compared with disposable N95s, while maintaining > 98 % filtration efficiency; no outbreak of nosocomial COVID‑19 was reported in 2025 [Japanese Society of Infection Prevention 2025].

Recommendations for Policymakers and administrators

1. Official WHO guideline amendment – Publish an update that classifies respirator‑level PPE as the baseline for all patient‑contact activities, with surgical masks reserved only for non‑clinical, administrative settings.
2. National regulatory alignment – Encourage ministries of health to adopt the WHO amendment into local infection‑control legislation within 12 months.
3. Funding mechanisms – Allocate dedicated budget lines for PPE procurement, fit‑testing infrastructure, and training programs, leveraging WHO’s Global Fund for Pandemic Preparedness.
4. Monitoring and evaluation – Deploy a real‑time dashboard tracking respirator availability, fit‑test compliance, and healthcare‑associated infection rates, enabling rapid policy adjustments.

Practical Tips for Frontline Staff

• Perform a seal check before each shift: inhale sharply and feel for air leakage around the edges.
• Rotate respirators using a logbook to ensure each unit does not exceed its validated reuse limit.
• Store respirators in breathable containers (e.g., paper bags) to prevent moisture buildup that can degrade filter performance.
• Stay hydrated – Proper hydration reduces facial skin irritation that can compromise the mask seal.

---

Sources: CDC (2025), WHO Technical Advisory Group (2025), IRPA Position Paper (2025), Lancet RCT (2023), NIOSH Laboratory Study (2022), EPA (2025), BMJ (2024), Health Economics Review (2025), European Journal of Infection Control (2025), Japanese Society of infection Prevention (2025).